Mazor Robotics (NASDAQ:MZOR) was downgraded by research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Saturday.

Several other equities research analysts have also recently commented on the company. Zacks Investment Research raised Mazor Robotics from a “sell” rating to a “hold” rating in a research note on Thursday, November 16th. TheStreet raised Mazor Robotics from a “d” rating to a “c-” rating in a research note on Wednesday, November 8th. Needham & Company LLC reissued a “hold” rating on shares of Mazor Robotics in a research note on Tuesday, November 7th. Ladenburg Thalmann Financial Services set a $67.00 price target on Mazor Robotics and gave the company a “buy” rating in a research note on Monday, October 30th. Finally, Barclays cut Mazor Robotics from an “equal weight” rating to an “underweight” rating and lowered their price target for the company from $55.00 to $34.00 in a research note on Thursday, October 19th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the stock. Mazor Robotics presently has a consensus rating of “Hold” and a consensus price target of $39.83.

Shares of Mazor Robotics (NASDAQ MZOR) traded down $0.32 during midday trading on Friday, hitting $57.83. The company had a trading volume of 310,115 shares, compared to its average volume of 547,292. Mazor Robotics has a 1-year low of $20.50 and a 1-year high of $65.97.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Dimensional Fund Advisors LP lifted its holdings in Mazor Robotics by 8.1% in the 2nd quarter. Dimensional Fund Advisors LP now owns 8,570 shares of the medical instruments supplier’s stock worth $296,000 after purchasing an additional 641 shares during the last quarter. ProVise Management Group LLC lifted its holdings in Mazor Robotics by 9.7% in the 3rd quarter. ProVise Management Group LLC now owns 13,395 shares of the medical instruments supplier’s stock worth $661,000 after purchasing an additional 1,187 shares during the last quarter. Royal Bank of Canada lifted its holdings in Mazor Robotics by 9.2% in the 2nd quarter. Royal Bank of Canada now owns 21,663 shares of the medical instruments supplier’s stock worth $749,000 after purchasing an additional 1,819 shares during the last quarter. Ladenburg Thalmann Financial Services Inc. lifted its holdings in Mazor Robotics by 107.3% in the 3rd quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,811 shares of the medical instruments supplier’s stock worth $188,000 after purchasing an additional 1,973 shares during the last quarter. Finally, Private Advisor Group LLC lifted its holdings in Mazor Robotics by 17.3% in the 3rd quarter. Private Advisor Group LLC now owns 14,834 shares of the medical instruments supplier’s stock worth $780,000 after purchasing an additional 2,189 shares during the last quarter. Hedge funds and other institutional investors own 26.46% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Mazor Robotics (MZOR) Downgraded to “Buy” at BidaskClub” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://www.thecerbatgem.com/2017/12/02/mazor-robotics-mzor-downgraded-to-buy-at-bidaskclub.html.

Mazor Robotics Company Profile

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.

Analyst Recommendations for Mazor Robotics (NASDAQ:MZOR)

Receive News & Stock Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related stocks with our FREE daily email newsletter.